MedPath

se of Inhaled vs intravenous sedation & its effect on incidence of delirium

Not Applicable
Conditions
Health Condition 1: O- Medical and SurgicalHealth Condition 2: 8- Other Procedures
Registration Number
CTRI/2022/09/045363
Lead Sponsor
Tata Memorial Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Age 18-80 years

2.BMI 25 to 35 Kg/m2

3.Anticipated Mechanical ventilation for > 24 hrs.

4.Patients who are mechanically ventilated within 48hrs of ICU admission

5.Hemodynamically stable patients (i.e., MAP >65mmHg) with or without vasoactive agents.

6.RASS score -1 to +4 on opioid infusion

7.Patients / surrogate decision maker, willing to enroll in the trial by giving written informed consent. We shall ask for provision of deferred informed consent from the respective IECs.

Exclusion Criteria

1.Patients who as per clinicianââ?¬•s judgement, need deep sedation (RASS -4 or deeper) such as those with severe head injury (GCS < 9) with raised intracranial pressure, severe ARDS (P/F < 100), etc.

2.Malnourished or morbidly obese patients (35 > BMI < 24.9 Kg/m2)

3.Need for neuromuscular blocking agents either as repeated boluses or infusion

4.Contraindications to use of HME filter during mechanical ventilation, these may include, but not limited to: excessive secretions or pulmonary hemorrhage likely to block the filter, indications for reducing apparatus dead space, such as respiratory acidosis

5.Ventilation with Tidal volume below 200 ml

6.Pregnant or breast-feeding women.

7.Family or personal history of malignant hyperthermia.

8.Patients already receiving sedation for more than > 48 hours.

9.Refusal of consent or withdrawal of consent for use of data.

10.Need for elective postoperative ventilation for < 24 hours.

11.Patients with substance abuse, deliberate self harm or any condition that warrants administration of any of the study drugs or any drug that belong to the study drug classification.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath